Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Atherosclerosis. 2010 Dec 21;215(1):223–228. doi: 10.1016/j.atherosclerosis.2010.12.012

Table 2.

Odds ratios (95% confidence intervals) for reported use of prescribed lipid-lowering drugs after deregulation of simvastatin by 10-year CHD risk category at baseline and adjusted for age and sex

Moderate risk group (N = 1,180) High risk group (N = 2,451)
Ethnicity
 White 1.00 (reference) 1.00 (reference)
 South Asian 2.44 (1.20, 4.95) p=0.01 1.64 (1.21, 2.23) p=0.001
 Afro-Caribbean 0.37 (0.05, 2.86) p=0.34 0.92 (0.56, 1.51) p=0.75
 Other 1.46 (0.15, 14.1) p=0.74 1.18 (0.50, 2.79) p=0.71
Employment grade
 High 1.00 (reference) 1.00 (reference)
 Intermediate 0.74 (0.55, 1.01) p=0.06 0.99 (0.83, 1.19) p=0.94
 Low 0.89 (0.46, 1.75) p=0.74 1.06 (0.78, 1.43) p=0.70